Lack of a Clinically Significant Pharmacokinetic Drug Interaction Between Tiagabine and Valproate

1998 ◽  
Vol 5 (2) ◽  
pp. 73-80 ◽  
Author(s):  
Linda E. Gustavson ◽  
Kenneth W. Sommerville ◽  
Galen F. Witt ◽  
Helen J. Guenther ◽  
G. Richard Granneman ◽  
...  
2021 ◽  
Vol 94 ◽  
pp. 100619
Author(s):  
Vijayakumar Thangavel Mahalingam ◽  
Ilango Kaliappan ◽  
Satish Kumar Rajappan Chandra ◽  
Melvin George ◽  
Mohan Kumar Ramasamy ◽  
...  

Drug Safety ◽  
2006 ◽  
Vol 29 (9) ◽  
pp. 769-784 ◽  
Author(s):  
Henning Blume ◽  
Frank Donath ◽  
Andr?? Warnke ◽  
Barbara S Schug

2005 ◽  
Vol 49 (10) ◽  
pp. 4386-4389 ◽  
Author(s):  
Marta Boffito ◽  
Anton Pozniak ◽  
Brian P. Kearney ◽  
Christopher Higgs ◽  
Anita Mathias ◽  
...  

ABSTRACT A study explored the pharmacokinetics of tenofovir (300 mg administered once daily) and nelfinavir (1,250 mg twice daily) when coadministered in 29 healthy volunteers. Tenofovir, nelfinavir, and M8 pharmacokinetics was unaltered when tenofovir and nelfinavir were coadministered, and tenofovir administration did not affect the M8/nelfinavir area under the concentration-versus-time curve over the dosing interval (AUCtau) ratio. No interaction between tenofovir and nelfinavir was observed.


2011 ◽  
Vol 51 (1) ◽  
pp. 84-92 ◽  
Author(s):  
Gopal Krishna ◽  
Donna Vickery ◽  
Lei Ma ◽  
Xin Yu ◽  
Carl Noren ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document